ABVC BioPharma, Inc. (ABVC) DCF Valuation

ABVC BioPharma, Inc. (ABVC) DCF Valoración

US | Healthcare | Biotechnology | NASDAQ
ABVC BioPharma, Inc. (ABVC) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

ABVC BioPharma, Inc. (ABVC) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus estrategias de inversión con la calculadora ABVC DCF! Explore los datos financieros auténticos de ABVC BioPharma, Inc., ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de ABVC.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .7 .5 .4 1.0 .2 .1 .1 .1 .1 .1
Revenue Growth, % 0 -31.16 -26.34 172.57 -84.28 -10.45 -10.45 -10.45 -10.45 -10.45
EBITDA -3.5 -10.4 -11.0 -15.2 -8.1 -.1 -.1 -.1 -.1 -.1
EBITDA, % -494.95 -2147.16 -3083.68 -1567.03 -5335.18 -100 -100 -100 -100 -100
Depreciation .1 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 7.85 7.69 3.37 2.45 18.72 8.02 8.02 8.02 8.02 8.02
EBIT -3.5 -10.4 -11.0 -15.2 -8.2 -.1 -.1 -.1 -.1 -.1
EBIT, % -502.8 -2154.85 -3087.05 -1569.49 -5353.9 -100 -100 -100 -100 -100
Total Cash .1 4.3 5.9 .2 .1 .1 .1 .1 .1 .1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .6 1.0 1.7 1.4 .8
Account Receivables, % 91.28 206.9 481.37 141.22 498.3
Inventories -.5 -.8 .0 1.3 .0 .0 .0 .0 .0 .0
Inventories, % -67.97 -173.83 7.3 134.72 0 -12.13 -12.13 -12.13 -12.13 -12.13
Accounts Payable .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Accounts Payable, % 3.42 4.77 0 0 0 1.64 1.64 1.64 1.64 1.64
Capital Expenditure .0 .0 .0 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 0 0 -4.92 -12.34 -13.91 -6.23 -6.23 -6.23 -6.23 -6.23
Tax Rate, % 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3
EBITAT -3.5 -10.2 -11.8 -16.0 -8.1 -.1 -.1 -.1 -.1 -.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -3.5 -10.2 -13.4 -17.0 -6.1 .5 -.1 -.1 -.1 -.1
WACC, % 55.33 55.27 56.33 56.33 55.65 55.78 55.78 55.78 55.78 55.78
PV UFCF
SUM PV UFCF .2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt 2
Equity Value -2
Diluted Shares Outstanding, MM 4
Equity Value Per Share -0.46

What You Will Receive

  • Customizable Excel Template: An adaptable Excel-based DCF Calculator featuring pre-filled real ABVC financials.
  • Actual Data: Historical performance data and future estimates (highlighted in the yellow cells).
  • Flexible Forecasting: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect ABVC’s valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Centric Layout: Organized for clarity and simplicity, complete with step-by-step guidance.

Key Features

  • Customizable Research Parameters: Adjust essential variables such as clinical trial timelines, market penetration rates, and R&D expenditures.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other key metrics with ease.
  • High-Precision Accuracy: Leverages ABVC's actual financial data for dependable valuation results.
  • Effortless Scenario Analysis: Evaluate various hypotheses and analyze results without hassle.
  • Efficiency Booster: Remove the complexity of creating intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file for ABVC BioPharma, Inc. (ABVC).
  2. Step 2: Review ABVC's pre-filled financial data and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model refresh in real-time as you modify assumptions.
  5. Step 5: Evaluate the outputs and leverage the findings for investment strategies.

Why Choose This Calculator for ABVC BioPharma, Inc. (ABVC)?

  • Accurate Data: Utilize real ABVC financials for dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Built-in calculations save you from starting from square one.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: An intuitive design and clear instructions make it accessible for users of all levels.

Who Should Use This Product?

  • Biotech Students: Explore drug development processes and apply theoretical knowledge with real-world data.
  • Researchers: Utilize advanced models for analyzing clinical trial results in coursework or studies.
  • Investors: Evaluate your investment strategies and assess valuation projections for ABVC BioPharma, Inc. (ABVC).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech companies.
  • Healthcare Entrepreneurs: Understand the valuation methods used for public biotech firms like ABVC BioPharma, Inc. (ABVC).

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for ABVC BioPharma, Inc. (ABVC).
  • Real-World Data: ABVC’s historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into ABVC's performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to ABVC.
  • Dashboard with Visual Outputs: Charts and tables designed to provide clear, actionable results for ABVC BioPharma, Inc. (ABVC).

No products were found matching.